A randomized, placebo-controlled trial in Tunisia treating cutaneous leishma ni a sis with par o mo my cin ointment ,
A randomized, placebo-controlled trial of a two-week regimen of aminosidine (par o mo my cin) ointment for treatment of cutaneous leish ma ni a sis in Iran, Am J Trop Med Hyg, vol.53, pp.648-51, 1995. ,
Complexities of Assessing the Disease Burden Attributable to Leishmaniasis, PLoS Neglected Tropical Diseases, vol.4, issue.10, p.313, 2008. ,
DOI : 10.1371/journal.pntd.0000313.t001
Interventions for American cutaneous and mucocutaneous leish ma ni a sis, Cochrane Database Syst Rev, vol.2, p.4834, 2009. ,
Is Paromomycin an Effective and Safe Treatment against Cutaneous Leishmaniasis? A Meta-Analysis of 14 Randomized Controlled Trials, PLoS Neglected Tropical Diseases, vol.14, issue.2, p.381, 2009. ,
DOI : 10.1371/journal.pntd.0000381.s002
Interventions for Old World cutaneous leish ma ni a sis, Cochrane Database Syst Rev, vol.4, p.5067, 2008. ,
Designing and Reporting Clinical Trials on Treatments for Cutaneous Leishmaniasis, Clinical Infectious Diseases, vol.51, issue.4, pp.409-428, 2010. ,
DOI : 10.1086/655134
Traitement des leishmanioses en France??: proposition d???un r??f??rentiel consensuel, La Presse M??dicale, vol.40, issue.2, pp.173-84, 2011. ,
DOI : 10.1016/j.lpm.2010.09.023
Consultative meeting to develop a strategy for treatment of cutaneous leish ma ni a sis: Institute Pasteur The sensitivity of Leishmania species to aminosidine, Kinetoplastid Biol Dis J Antimicrob Chemother, vol.635, pp.3-12577, 1995. ,
In vitro and in vivo interactions between miltefosine and other antileishmanial drugs Pharmacokinetics of intramuscularly administered aminosidine in healthy subjects, Antimicrob Agents Chemother Antimicrob Agents Chemother, vol.5041, issue.14, pp.73-9982, 1997. ,
Injectable par o momy cin for visceral leish ma ni a sis in India Aminosidine (par o mo my cin) versus sodium stibogluconate for the treatment of American cutaneous leish ma ni a sis, N Engl J Med Trans R Soc Trop Med Hyg, vol.35688, issue.16, pp.2571-81700, 1994. ,
Limited efficacy of injectable aminosidine as single-agent therapy for Colombian cutaneous leish ma ni a sis Parenteral aminosidine is not effective for Peruvian mucocutaneous leishma ni a sis, Trans R Soc Trop Med Hyg Am J Trop Med Hyg, vol.8876, issue.18, pp.695-703, 1994. ,
Topical treatment for cutaneous leish ma ni a sis, Curr Opin Investig Drugs, vol.3, pp.538-582, 2002. ,
Development of topical treatment for cutaneous leishmaniasis caused by Leishmania major in experimental animals., Antimicrobial Agents and Chemotherapy, vol.26, issue.5, pp.745-51, 1984. ,
DOI : 10.1128/AAC.26.5.745
Topical treatment of cutaneous leish ma ni a sis Randomized, controlled, double-blind trial of topical treatment of cutaneous leish ma ni a sis with par o mo my cin plus methylbenzethonium chloride ointment in Guatemala A double-blind clinical trial of the treatment of cutaneous leish ma ni a sis with par o mo my cin ointment Treatment of 'Old World' cutaneous leishma ni a sis with aminosidine ointment: results of an open study in London, The leish maniases in biology and medicine, pp.284-292, 1986. ,
Successful topical treatment of murine cutaneous leish ma ni a sis with a combination of par o mo my cin (aminosidine ) and gentamicin Leishmania mexicana and Leishmania major: attenuation of wildtype parasites and vaccination with attenuated lines Leishmania major H-line attenuated under pressure of gentamicin, induces a Th1 response which protects susceptible BALB/c mice against infection with virulent L. major, J Parasitol J Infect Dis Parasitology, vol.85187, issue.136, pp.354-363, 1999. ,
396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leish ma ni asis: a phase 2, randomized, double blind, placebo controlled study, PLoS Negl Trop Dis, vol.2793, issue.5, p.432, 2009. ,